Immunohematology Market to Reach $3.17 Billion by 2029 at 5.7% CAGR

 Aimed at strategic decision-makers, this report explores current opportunities, emerging trends, and market dynamics shaping the immunohematology sector.


What Is The Projected Market Size & Growth Rate Of The Immunohematology Market?
The immunohematology market size has grown steadily in recent years. It will grow from $2.46 billion in 2024 to $2.55 billion in 2025 at a compound annual growth rate (CAGR) of 3.6%. The growth in the historic period can be attributed to advancements in blood transfusion science, the prevalence of blood disorders, the expansion of blood banks, government initiatives for blood safety, increased surgical procedures, and awareness of transfusion-related risks

The immunohematology market size is expected to see strong growth in the next few years. It will grow to $3.17 billion in 2029 at a compound annual growth rate (CAGR) of 5.7%. The growth in the forecast period can be attributed to increasing demand for point-of-care testing, emergence of novel blood products, expansion of healthcare infrastructure, genetic testing for blood compatibility, and regulatory support for blood safety. Major trends in the forecast period include automation and high-throughput systems, molecular blood typing methods, antibody detection techniques, patient blood management programs, integration of ai in analysis, telemedicine integration.

Get your free sample today:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10295&type=smp

What Is The Crucial Factor Driving The Global Immunohematology Market?
The rising prevalence rate of hematological disorders is expected to propel the growth of the immunohematology market going forward. Hematological disorders are a diverse group of conditions that affect the blood and the components of the blood, such as red blood cells, white blood cells, platelets, and plasma. Immunohematology is essential for safe and effective blood transfusions, as it helps to prevent transfusion reactions caused by incompatible blood types or the presence of antibodies in the recipient's blood. Immunohematology techniques are also used to diagnose and treat diseases related to the immune system, which may impact the hematological system. For instance, according to Cancer Research UK, a UK-based research organization, the average number of new leukemia cases caused by hematological disorders in the UK is expected to climb from roughly 12,400 cases in 2023-2025 to around 14,500 cases in 2038-2040. Therefore, the rising prevalence rate of hematological disorders is driving the growth of the immunohematology market.

Segment Covered In The Immunohematology Market Report
The immunohematology market covered in this report is segmented –

1) By Product: Analyzers And Systems, Reagents
2) By Technology: Biochips, Erythrocyte-Magnetized Technology (Met), Gel Cards, Microplates, Polymerase Chain Reaction (PCR)
3) By Disease: Blood-Related Diseases, HIV, Hepatitis
4) By Application: Pretransfusion Testing, Investigation Of Immune Hemolysis, Perinatal Testing, Blood Group Phenotyping, Leucocyte And Platelet Serology
5) By End User: Blood Banks, Diagnostic And Reference Laboratories, Hospitals, Academic And Research Institutes

Subsegments:
1) By Analyzers And Systems: Blood Typing Analyzers, Cross-Matching Analyzers, Gel Card Systems
2) By Reagents: Blood Grouping Reagents, Antisera, Control Serum

What Are The Prominent Trends In The Immunohematology Market?
Major companies operating in the immunohematology market are focused on developing innovative diagnostic solutions, such as soluble recombinant proteins designed to overcome the interference of the cancer therapy daratumumab. Soluble recombinant protein is a protein produced through recombinant DNA technology that remains properly folded and functional in a soluble form within a host cell or solution, facilitating its use in research and therapeutic applications. For instance, in November 2023, Grifols, S.A., a Spain-based pharmaceutical company, launched the Grifols sCD38 solution. Grifols' sCD38 is the first-ever soluble recombinant protein. Developed to address the interference caused by the cancer therapy daratumumab in vital blood transfusion compatibility testing. Specifically designed for multiple myeloma patients, this groundbreaking solution blocks daratumumab from attaching to CD38 proteins on red blood cells, ensuring precise pre-transfusion test outcomes. By facilitating a more efficient process for screening, identification, and crossmatching, Grifols sCD38 enhances blood transfusion protocols and minimizes delays in delivering lifesaving transfusions.

Key Player In The Immunohematology Market
Major companies operating in the immunohematology market include Ortho Clinical Diagnostics Inc., Immunocor Inc., Abbott Laboratories, Siemens Healthineers AG, Grifols S.A., Beckman Coulter Inc., Thermo Fisher Scientific Inc., Becton Dickinson and Company, Merck Co. & KGaA, Bio-Rad Laboratories, Sysmex Corporation, Danaher Corporation, Biosystems S.A., Roche Holdings AG, Mindray Medical International Limited, F.Hoffmann La-Roche Ltd., Biotest AG, Cardinal Health Inc., Quotient Limited, DiaSorin S.p.A., Lorne Laboratories Ltd., Biokit S.A., Avox Technologies, Diagnostic Automation/Cortez Diagnostics Inc., Inno-train Diagnostik GmbH, Drucker Diagnostics Inc., Immundia Diagnostics Pvt. Ltd.

View the full immunohematology market report here:
https://www.thebusinessresearchcompany.com/report/immunohematology-global-market-report

Global Immunohematology Market - Regional Insights:
North America was the largest region in the immunohematology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global immunohematology market during the forecast period. The regions covered in the immunohematology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

#Contact Us:#

The Business Research Company

Market Research Reports

Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267

Email: info@tbrc.info


#Follow Us On:#

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Comments

Popular posts from this blog

Ammonia Market Forecast 2025 – Industry Trends, Challenges & Strategic Intelligence

Poultry Disinfectant Market Outlook 2025 – Global Demand, Trends & Forecast

Ammonium Sulfate Market Outlook 2025–2034 – Forecast, Trends & Growth Strategies